In the first human clinical trial, researchers at Massachusetts General Hospital (MGH) and surgeons at Beth Israel Deaconess Medical Center
Day: January 2, 2021
With COVID-19 exacerbating superbug threat, researchers ID new weapon
As scientists around the globe wage war against a novel, deadly virus, one University of Colorado Boulder lab is working
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled
Self-learning algorithms analyze medical imaging data
Imaging techniques enable a detailed look inside an organism. But interpreting the data is time-consuming and requires a great deal
Discovery about how cancer cells evade immune defenses inspires new treatment approach
Cancer cells are known for spreading genetic chaos. As cancer cells divide, DNA segments and even whole chromosomes can be
Protein twist and squeeze confers cancer drug resistance
In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), discovered that a protein
How did trauma centers respond to COVID-19? New processes provide care to trauma patients while keeping providers safe
As the COVID-19 pandemic emerged, trauma centers faced unprecedented obstacles to providing care for injured patients. A look at steps
EXPLAINER: Should vaccine volunteers now get the real thing?
Tens of thousands of Americans have volunteered to test COVID-19 vaccines, but only about half of them got the real
Race to vaccinate millions in US off to slow, messy start
Terry Beth Hadler was so eager to get a lifesaving COVID-19 vaccination that the 69-year-old piano teacher stood in line
Nanoparticle drug-delivery system developed to treat brain disorders
In the past few decades, researchers have identified biological pathways leading to neurodegenerative diseases and developed promising molecular agents to
